Events

Investing in megatrends with deep tech and impact: digitisation, urbanisation, and health & age



Our world is changing at a rapid pace. Digitisation, environmental destruction, trade disputes and new technologies are shaping our lives and thus our future like never before. Today, an impact led investment portfolio must withstand stronger storms and find new and different sources of return than in the past. Old structures are being replaced by new paradigms. Cards are being reshuffled. Global Megatrends such as urbanization, digitisation, or health & age are impacting globally business models and the competitiveness of companies, industries and countries.

During this event (deep)tech venture capital firm LUMO Labs, Peter Brock from BeeWyzer, and future orientated Suisse-german wealth manager Globalance will elaborate on the improvement of the quality of life and wellbeing of individuals by investing in venture capital or in secondary markets. The event is meant to be practical and down to earth by presenting companies and start ups who address today’s global challenges and foster a better future by innovation and economic progression.

LUMO Labs

LUMO Labs, based at the High Tech Campus in Eindhoven, the Netherlands, focuses on investments that improve the quality of Life and wellbeing of individuals and for medium and long-term relief of the ever-increasing strain on (public) healthcare, social welfare, and the planet. With a target fund size of EUR 100 mio, LUMO Labs invest in tech startups (mainly seed stage) using Emerging & Disruptive Technologies (AI, Data, Blockchain, Iot,  AR/VR, and Digital Security) to solve social and environmental challenges within the 4 following SDGs: Health & Wellbeing, Quality Education, Sustainable City and Climate Action. They invest in Europe with a primary focus on Benelux/Germany and a secondary focus on Nordics/Baltics and Iberia. They also support the founders of our portfolio companies based on a coaching program based on our experience as entrepreneurs. This program is based on four pillars, Excellent Leadership, Storytelling, Product Market Fit, and Follow-on investment. Besides reaching the impact targets we aim for a multiple ≥4 and a 22% IRR per annum.

Hema.to

Hema.to automates complex blood data analysis through AI-powered cytometry, reducing lab analysis time from ~20 minutes to 1 minute, eliminating human subjectivity in detecting leukaemia and lymphoma, and eradicating 90% of false negatives for secondary pathologies. Hema.to’s AI pulls data from a massive database of over 600,000 files from over 20 leading centers. With their CE-marked AI models for clinical-grade performance and their new end-to-end solution in the process of a new certification, Hema.to is already helping labs and hospitals across Europe diagnose blood cancers.

“At hema.to we like to say that we want to ‘make your blood speak’”, says Karsten Miermans, hema.to’s CEO and co-founder. “Every 3rd person suffers from a life-altering immune disease at some point in their life. Blood data holds the key to the immune system, but at present life-threatening illnesses like leukaemia or lymphoma, can be overlooked in blood analysis—even when the data that indicates otherwise is right there. Through the AI models on our platform, we pull this data to the surface to get every patient an accurate diagnosis and treatment as early as possible. This is how we save lives.”

Globalance Invest

Globalance Invest GmbH, based in Munich, is a German wealth management and asset management company licensed by BaFin. Globalance pursues a very high level of transparency in future-oriented and sustainable investments. Globalance assasses how investments and economic activity impacts the economy, society, and the environment. The parent company is Globalance Bank AG, Zurich, founded in 2019. The founders of the Swiss bank also founded Sustainable Asset Management (now RobecoSAM) and are the creators of the Dow Jones Sustainability Index. Clients entrust Globalance with around 2,2 billion euros in assets.


Dagmar van Ravenswaay Claasen

Senior Partner LUMO Labs

Dagmar is senior partner at LUMO Labs. She is a driven professional with a passion for contributing to a greater cause and achieving meaningful change. Her focus is on helping startups and scale-ups realise their impact and creating opportunities from regulation. Because she believes in the importance of the integrity and sustainability of companies, she’s been driving change in various settings. After a career as a lawyer, she held several leadership positions at the Dutch Central Bank and started a biological-only wine company. In 2016, she made the move to the global fintech company Adyen, where she was part of the IPO team. Besides LUMO Labs, she’s involved as a Board advisor/SB member in impact-driven tech scale-ups. 

Andy Lürling

Founding Partner LUMO Labs

Andy is an entrepreneur-turned-investor passionate about the convergence of technologies and impact-driven innovation. After early roles in strategy and business development, he co-founded a tech company in 2003 and later launched a VC-backed startup using satellite and gaming technology, which exited successfully in 2011. In 2016, he and Sven founded LUMO Labs, launching their first external fund in 2020. His global network spans scientists, investors, corporates, and governments. Andy serves on the advisory board of The Next Web (a Financial Times company), is a NEXUS Impact Society member, and frequently judges at events like ChangeNOW, TNW, and 4YFN. He also represents startups and scale-ups in the Dutch AI Coalition strategy team.

Peter Brock

BeeWyzer GmbH, Family Office Services, Managing Partner

Peter, the moderator of the discussion, is an internationally acclaimed family office expert (formerly HSBC, Deloitte and EY), nextgen educator and advisor on impact investing and on sustainable wealth transfer across generations. He is also co-founder of BeeWyzer and a member of LUMO Labs’ Scientific, Industry and Impact Board of Advisors amongst other mentoring or expert roles in the impact investing ecosystem.

Werner Hedrich

Managing Director Globalance Invest GmbH

Werner Hedrich was CEO of Morningstar in Germany and Austria from 2011 – 2018. Morningstar is a global research, analysis and financial information company. In collaboration with research colleagues, W. Hedrich launched a Morningstar ESG rating for investment funds in 2016 to create a uniform and transparent research standard. Before becoming Managing Director, Werner Hedrich spent six years developing and managing research for Morningstar in German-speaking Europe. He had previously worked as a market strategist, equity sales and equity analyst. Werner Hedrich holds a degree in political science from the Free University of Berlin and studied European Studies in Brussels.


Programme

18:00

|

Reception

18:15

|

Welcome
Werner Hedrich, Globalance Invest

18:20

|

Elevator pitch 1
LUMO Labs

18:35

|

Elevator pitch 2
Werner Hedrich, Globalance Invest

18:50

|

Panel and discussion with attendees

19:30

|

Venture Start-up 1

Hema.to

19:45

|

Venture Start-up 2

tbc

20:00

|

Come together

with drinks and finger food

End 21:30h

We are looking forward to welcoming you at our premises at Maximilianstraße 35 C, 80539 Munich (please use the entrance via Herzog-Rudolf-Straße). 


Feel free to register with a companion. Please note that we have limited seating available for attendees.


In cooperation with:

Journey